Last reviewed · How we verify

BaidI Quzhi granule — Competitive Intelligence Brief

BaidI Quzhi granule (BaidI Quzhi granule) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Traditional Chinese Medicine / Cardiovascular.

phase 3 Traditional Chinese Medicine / Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

BaidI Quzhi granule (BaidI Quzhi granule) — Shanghai Yueyang Integrated Medicine Hospital. BaidI Quzhi granule is a traditional Chinese medicine formulation designed to improve blood circulation and remove blood stasis.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
BaidI Quzhi granule TARGET BaidI Quzhi granule Shanghai Yueyang Integrated Medicine Hospital phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). BaidI Quzhi granule — Competitive Intelligence Brief. https://druglandscape.com/ci/baidi-quzhi-granule. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: